未登录
分享
收藏
分享
收藏JNJ-87801493 (CD20xCD28), a Potential First-in-Class CD20 Targeted CD28 Costimulatory Bispecific Antibody, Enhances the Activity of B-Cell Targeting T-Cell Engagers in Preclinical ModelsJNJ-87801493 (CD20xCD28),一种潜在的首创CD20靶向CD28共刺激双特异性抗体,增强了B细胞靶向T细胞结合剂在预临床模型中的活性。
Fontan, Lorena; Zwolak, Adam; Guimerans-Lorenzo, Irene; Bekkers, Mariette; Hein, Nicholas; Vloemans, Nele; Trella, Emanuele; Smets, Tina; Cornelissen, Ivo; Assefa, Alemu; Verbist, Bie; Amorim, Ricardo; Seth, Pankaj; Dash, Ranjeet Prasad; Luistro, Leopoldo; Mattson, Bethany; Dragovich, Matthew A.; Hedvat, Michael; Moore, Gregory L.; Desjarlais, John R.; Kutlu, Olivia; Erhardt, Joseph; Philippar, Ulrike
分享
收藏
分享
收藏
分享
收藏
分享
收藏